Vimarsana
Biggest News Aggregation in the World

Glial Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Glial Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Glial Cells Today - Breaking & Trending Today

About Brain Tumor - Vimarsana News

About Brain Tumor

Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.

Ibogaine By David Dardashti Unravels the Science of Glial - Vimarsana News

Ibogaine By David Dardashti Unravels the Science of Glial

Research Reveals Mental Growth Directly Linked to Emotional Responses...

New research reveals cell death contributing to Alzheimer's and vascular dementia - Vimarsana News

New research reveals cell death contributing to Alzheimer's and vascular dementia

Researchers at Oregon Health & Science University said in a study they have discovered a new way a type of cell important for brain health is dying in the brain

Source: katu.com
INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update - Vimarsana News

INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update

Company to Host Conference Call Today, November 1, at 4:30pm ETBOCA RATON, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its financial results for the quarter ended September 30, 2023 and provides a business update. Q3 2023 Corporate Highlights: DN-TNF Platform Highlights (XPro™): AD02 blinded randomized p

Source: yahoo.com
INmune Bio Inc. Announces Third Quarter 2023 Results and - Vimarsana News

INmune Bio Inc. Announces Third Quarter 2023 Results and

Company to Host Conference Call Today, November 1, at 4:30pm ET...